| Trial ID: | L4901 |
| Source ID: | NCT04957914
|
| Associated Drug: |
Insulin Glargine
|
| Title: |
A Study of LY3209590 on Low Blood Sugar in Participants With Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Insulin Glargine|DRUG: LY3209590
|
| Outcome Measures: |
Primary: Incidence of Documented Hypoglycemia, Incidence of Documented Hypoglycemia, Baseline through Day 186 |
|
| Sponsor/Collaborators: |
Sponsor: Eli Lilly and Company
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
54
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2021-07-14
|
| Completion Date: |
2022-10-17
|
| Results First Posted: |
|
| Last Update Posted: |
2022-11-16
|
| Locations: |
Profil Institut für Stoffwechselforschung, Neuss, Nordrhein-Westfalen, 41460, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT04957914
|
